IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knoll Capital Management, LLC

Q2 2018 Holdings

Filed 2018-08-14 | 19 holdings | $3.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Anavex Life Sciences Corp(AVXL)COM NEW032797300$1.9M724,20559.7%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$987.0K124,09631.1%
Chromadex Corp(NAGE)COM NEW171077407$178.0K47,8665.6%
Abeona Therapeutics Inc(ABEO1EUR)COM00289Y107$37.8K2,359,7671.2%
Biohaven Pharmactl Hldg Co L(BHVN)COMG11196105$29.6K749,8150.9%
Corbus Pharmaceuticals Hldgs(CRBPEUR)COM21833P103$19.8K3,913,8740.6%
Electrocore Inc(ECORGBP)COM28531P103$6.6K396,8250.2%
Ampio Pharmaceuticals Inc.COM03209T109$5.7K2,595,4840.2%
Krystal Biotech Inc(KRYS)COM501147102$4.5K300,0000.1%
Entera Bio Ltd(ENTX)SHSM40527109$3.0K475,5400.1%
Galmed Pharmaceuticals Ltd(GLMD)SHSM47238106$2.5K210,0000.1%
Vascular Biogenics LTDCOMM96883109$2.0K896,7710.1%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$91875,2380.0%
Soligenix Inc.COM834223307$813837,8000.0%
Volition RX LTD(VNRX)COM928661107$703351,5380.0%
Evoke Pharma IncCOM30049G104$688275,0000.0%
Lipocine Inc NewCOM53630X104$6550,0000.0%
Catasys IncCOM149049504$619,0810.0%
Advaxis Inc.W EXP 07/15/201007624117$20112,5000.0%